Retreatment of rheumatoid arthritis patients with 1×1000 mg rituximab results in sustained clinical response in clinical responders initially treated with 2×1000 mg rituximab
Retreatment of rheumatoid arthritis patients with 1×1000 mg rituximab results in sustained clinical response in clinical responders initially treated with 2×1000 mg rituximab